跳转至内容
Merck
CN

CDS021593

吡格列酮

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C19H20N2O3S
分子量:
356.44
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
NACRES:
NA.21
Form:
solid
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

AldrichCPR

form

solid

SMILES string

O=C(N1)C(SC1=O)CC(C=C2)=CC=C2OCCC(N=C3)=CC=C3CC

InChI

1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)

InChI key

HYAFETHFCAUJAY-UHFFFAOYSA-N

Gene Information

human ... PPARG(5468)

Other Notes

请注意,Sigma-Aldrich 向早期发现研究人员提供该产品,作为独特化学品集合的一部分。Sigma-Aldrich 不收集本品的分析数据。买方负责确认产品标识和/或纯度。所有销售均为最终产品。
即使Sigma-Aldrich的标准销售条款和条件或Sigma-Aldrich与买方之间的协议中有任何相反的规定,SIGMA-ALDRICH仍“按原样”销售本产品,且不就本产品做出任何声明或保证,包括 (A) 适销性保证,(B) 特定用途的适合性保证,或 (C) 针对第三方知识产权侵权的保证,无论是否由法律、交易过程、履行过程、贸易使用或其他原因引起。


pictograms

Health hazardExclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Latifa Bakiri et al.
The Journal of experimental medicine, 214(5), 1387-1409 (2017-03-31)
Human hepatocellular carcinomas (HCCs), which arise on a background of chronic liver damage and inflammation, express c-Fos, a component of the AP-1 transcription factor. Using mouse models, we show that hepatocyte-specific deletion of c-Fos protects against diethylnitrosamine (DEN)-induced HCCs, whereas
Fumi Kano et al.
Scientific reports, 7(1), 15167-15167 (2017-11-11)
Cell-based assays are growing in importance for screening drugs and investigating their mechanisms of action. Most of the assays use so-called "normal" cell strain because it is difficult to produce cell lines in which the disease conditions are reproduced. In
Lawrence H Young et al.
Circulation, 135(20), 1882-1893 (2017-03-02)
Insulin resistance is highly prevalent among patients with atherosclerosis and is associated with an increased risk for myocardial infarction (MI) and stroke. The IRIS trial (Insulin Resistance Intervention after Stroke) demonstrated that pioglitazone decreased the composite risk for fatal or



全球贸易项目编号

货号GTIN
CDS021593-50MG04061828994007